Patents by Inventor Thomas Kundig

Thomas Kundig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11571474
    Abstract: The present invention relates to the use of a composition in a method of reducing the allergenicity of a cat. Moreover, the present invention relates to the use of a composition in a method of reducing the allergenicity of a cat for a human exposed to the cat. Furthermore, the present invention relates to compositions comprising a virus-like particle (VLP) and at least one Fel d1 protein. The compositions of the invention induce efficient immune responses, in particular antibody responses, in cats and are useful for the treatment and/or prevention of cat allergy.
    Type: Grant
    Filed: October 13, 2020
    Date of Patent: February 7, 2023
    Assignee: UNIVERSITÄT ZÜRICH
    Inventors: Martin Bachmann, Gary Jennings, Thomas Kündig, Gabriela Senti, Franziska Zabel
  • Publication number: 20210106676
    Abstract: The present invention relates to the use of a composition in a method of reducing the allergenicity of a cat. Moreover, the present invention relates to the use of a composition in a method of reducing the allergenicity of a cat for a human exposed to the cat. Furthermore, the present invention relates to compositions comprising a virus-like particle (VLP) and at least one Fel d1 protein. The compositions of the invention induce efficient immune responses, in particular antibody responses, in cats and are useful for the treatment and/or prevention of cat allergy.
    Type: Application
    Filed: October 13, 2020
    Publication date: April 15, 2021
    Inventors: Martin BACHMANN, Gary JENNINGS, Thomas KÜNDIG, Gabriela SENTI, Franziska ZABEL
  • Patent number: 10835600
    Abstract: The present invention relates to the use of a composition in a method of reducing the allergenicity of a cat. Moreover, the present invention relates to the use of a composition in a method of reducing the allergenicity of a cat for a human exposed to the cat. Furthermore, the present invention relates to compositions comprising a virus-like particle (VLP) and at least one Fel d1 protein. The compositions of the invention induce efficient immune responses, in particular antibody responses, in cats and are useful for the treatment and/or prevention of cat allergy.
    Type: Grant
    Filed: September 7, 2016
    Date of Patent: November 17, 2020
    Assignee: UNIVERSITÄT ZÜRICH
    Inventors: Martin Bachmann, Gary Jennings, Thomas Kündig, Gabriela Senti, Franziska Zabel
  • Publication number: 20180250387
    Abstract: The present invention relates to the use of a composition in a method of reducing the allergenicity of a cat. Moreover, the present invention relates to the use of a composition in a method of reducing the allergenicity of a cat for a human exposed to the cat. Furthermore, the present invention relates to compositions comprising a virus-like particle (VLP) and at least one Fel d1 protein. The compositions of the invention induce efficient immune responses, in particular antibody responses, in cats and are useful for the treatment and/or prevention of cat allergy.
    Type: Application
    Filed: September 7, 2016
    Publication date: September 6, 2018
    Inventors: Martin BACHMANN, Gary JENNINGS, Thomas KÜNDIG, Gabriela SENTI, Franziska ZABEL
  • Publication number: 20080199485
    Abstract: Embodiments of the invention disclosed herein relate to methods and compositions for exponentially increasing antigenic stimulation of class I MHC CD8+ T cell responses over that based in the art. Some embodiments relate to an immunogenic composition that enhances an immune response in a subject. In some embodiments, the immunogenic composition comprises an antigen in combination with an immunopotentiator or a biological response modifier (BRM). Overall, the invention disclosed herein demonstrates that increasing antigenic stimulation in a manner independent of the dose of the antigen enhances immunogenicity.
    Type: Application
    Filed: February 15, 2008
    Publication date: August 21, 2008
    Applicant: Mannkind Corporation
    Inventors: Thomas Kundig, Adrian Bot, Kent Andrew Smith, Zhiyong Qiu
  • Publication number: 20070003579
    Abstract: Heat-denatured allergen compositions of bee venom, grass pollen, birch pollen, and cat dander or hair for use in allergen-specific immunotherapy.
    Type: Application
    Filed: June 30, 2005
    Publication date: January 4, 2007
    Applicant: MannKind Corporation
    Inventor: Thomas Kundig
  • Publication number: 20060153844
    Abstract: The present invention includes use of a biological response modifier (BRM) to modulate an immune response in a subject while avoiding or limiting common side-effects associate with BRM use. The BRMs of the present invention can be injected into a secondary lymphatic organ of the subject or into an area of relatively high drainage into a secondary lymphatic organ of the subject. The modulated immune response can be general or antigen-specific.
    Type: Application
    Filed: December 29, 2005
    Publication date: July 13, 2006
    Inventors: Thomas Kundig, Adrian Bot
  • Publication number: 20060153858
    Abstract: Disclosed herein are methods for inducing an immunological CTL response to an antigen by sustained, regular delivery of the antigen to a mammal so that the antigen reaches the lymphatic system. Antigen is delivered at a level sufficient to induce an immunologic CTL response in a mammal and the level of the antigen in the mammal's lymphatic system is maintained over time sufficient to maintain the immunologic CTL response. Also disclosed is an article of manufacture for delivering an antigen that induces a CTL response in an animal.
    Type: Application
    Filed: December 19, 2005
    Publication date: July 13, 2006
    Inventors: Thomas Kundig, John Simard
  • Patent number: D792197
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: July 18, 2017
    Assignee: Olson Kundig, Inc.
    Inventor: Thomas Kundig
  • Patent number: D799933
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: October 17, 2017
    Assignee: OLSON KUNDIG, INC.
    Inventor: Thomas Kundig
  • Patent number: D818352
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: May 22, 2018
    Assignee: Olson Kundig, Inc.
    Inventor: Thomas Kundig
  • Patent number: D827422
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: September 4, 2018
    Assignee: OLSON KUNDIG, INC.
    Inventor: Thomas Kundig